Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Vasudevan

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Cell Reports|February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in EpendymomaS John Liu, Stephen T Magill, Harish N Vasudevan, et al.
Neurosurgery|August 30, 2020
A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After ResectionWilliam C Chen, Harish N Vasudevan, Abrar Choudhury, et al.
Journal of Neurosurgery|January 21, 2022
Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumorsWilliam C Chen, Matthieu Lafreniere, Christina Phuong, et al.
Nature Communications|January 12, 2024
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistanceHarish N Vasudevan, Emily Payne, Cyrille L Delley, et al.
JCI Insight|September 23, 2025
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastomaSixuan Pan, Kanish Mirchia, Emily Payne, et al.
Cancer Discovery|July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable DependenciesBriana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
JAMA Network Open|August 17, 2023
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to ImmunotherapyHarish N Vasudevan, Cyrille Delley, William C Chen, et al.
Nature Communications|September 24, 2020
Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningiomaStephen T Magill, Harish N Vasudevan, Kyounghee Seo, et al.
Neuro-Oncology Advances|October 15, 2019
Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survivalOlivier Morin, William C Chen, Farshad Nassiri, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Cell Reports|February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in EpendymomaS John Liu, Stephen T Magill, Harish N Vasudevan, et al.
Neurosurgery|August 30, 2020
A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After ResectionWilliam C Chen, Harish N Vasudevan, Abrar Choudhury, et al.
Journal of Neurosurgery|January 21, 2022
Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumorsWilliam C Chen, Matthieu Lafreniere, Christina Phuong, et al.
Nature Communications|January 12, 2024
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistanceHarish N Vasudevan, Emily Payne, Cyrille L Delley, et al.
JCI Insight|September 23, 2025
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastomaSixuan Pan, Kanish Mirchia, Emily Payne, et al.
Cancer Discovery|July 25, 2020
The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable DependenciesBriana C Prager, Harish N Vasudevan, Deobrat Dixit, et al.
JAMA Network Open|August 17, 2023
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to ImmunotherapyHarish N Vasudevan, Cyrille Delley, William C Chen, et al.
Nature Communications|September 24, 2020
Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningiomaStephen T Magill, Harish N Vasudevan, Kyounghee Seo, et al.
Neuro-Oncology Advances|October 15, 2019
Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survivalOlivier Morin, William C Chen, Farshad Nassiri, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Pageof 10